73 related articles for article (PubMed ID: 38725572)
41. The relationship between high-sensitivity CRP and polyclonal free light chains as markers of inflammation in chronic disease.
Burmeister A; Assi LK; Ferro CJ; Hughes RG; Barnett AH; Bellary S; Cockwell P; Pratt G; Hutchison CA
Int J Lab Hematol; 2014 Aug; 36(4):415-24. PubMed ID: 24188493
[TBL] [Abstract][Full Text] [Related]
42. Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences.
van Greevenbroek MM; Schalkwijk CG; Stehouwer CD
Neth J Med; 2013 May; 71(4):174-87. PubMed ID: 23723111
[TBL] [Abstract][Full Text] [Related]
43. Nine months of combined training improves ex vivo skeletal muscle metabolism in individuals with type 2 diabetes.
Sparks LM; Johannsen NM; Church TS; Earnest CP; Moonen-Kornips E; Moro C; Hesselink MK; Smith SR; Schrauwen P
J Clin Endocrinol Metab; 2013 Apr; 98(4):1694-702. PubMed ID: 23463651
[TBL] [Abstract][Full Text] [Related]
44. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis.
Wang X; Bao W; Liu J; Ouyang YY; Wang D; Rong S; Xiao X; Shan ZL; Zhang Y; Yao P; Liu LG
Diabetes Care; 2013 Jan; 36(1):166-75. PubMed ID: 23264288
[TBL] [Abstract][Full Text] [Related]
45. Progression from high insulin resistance to type 2 diabetes does not entail additional visceral adipose tissue inflammation.
Barbarroja N; Lopez-Pedrera C; Garrido-Sanchez L; Mayas MD; Oliva-Olivera W; Bernal-Lopez MR; El Bekay R; Tinahones FJ
PLoS One; 2012; 7(10):e48155. PubMed ID: 23110196
[TBL] [Abstract][Full Text] [Related]
46. Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis.
DeGoma EM; French B; Dunbar RL; Allison MA; Mohler ER; Budoff MJ
Atherosclerosis; 2012 Sep; 224(1):274-9. PubMed ID: 22846611
[TBL] [Abstract][Full Text] [Related]
47. Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population.
Dispenzieri A; Katzmann JA; Kyle RA; Larson DR; Therneau TM; Colby CL; Clark RJ; Mead GP; Kumar S; Melton LJ; Rajkumar SV
Mayo Clin Proc; 2012 Jun; 87(6):517-23. PubMed ID: 22677072
[TBL] [Abstract][Full Text] [Related]
48. An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease.
Braber S; Thio M; Blokhuis BR; Henricks PA; Koelink PJ; Groot Kormelink T; Bezemer GF; Kerstjens HA; Postma DS; Garssen J; Kraneveld AD; Redegeld FA; Folkerts G
Am J Respir Crit Care Med; 2012 Apr; 185(8):817-24. PubMed ID: 22227380
[TBL] [Abstract][Full Text] [Related]
49. Effect of exercise training modality on C-reactive protein in type 2 diabetes.
Swift DL; Johannsen NM; Earnest CP; Blair SN; Church TS
Med Sci Sports Exerc; 2012 Jun; 44(6):1028-34. PubMed ID: 22157880
[TBL] [Abstract][Full Text] [Related]
50. Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation.
Hutchison CA; Landgren O
Clin Chem; 2011 Oct; 57(10):1387-9. PubMed ID: 21836076
[No Abstract] [Full Text] [Related]
51. Metformin and exercise in type 2 diabetes: examining treatment modality interactions.
Boulé NG; Robert C; Bell GJ; Johnson ST; Bell RC; Lewanczuk RZ; Gabr RQ; Brocks DR
Diabetes Care; 2011 Jul; 34(7):1469-74. PubMed ID: 21602430
[TBL] [Abstract][Full Text] [Related]
52. Effects of exercise on inflammation markers in type 2 diabetic subjects.
Hopps E; Canino B; Caimi G
Acta Diabetol; 2011 Sep; 48(3):183-9. PubMed ID: 21431832
[TBL] [Abstract][Full Text] [Related]
53. Free immunoglobulin light chain: its biology and implications in diseases.
Nakano T; Matsui M; Inoue I; Awata T; Katayama S; Murakoshi T
Clin Chim Acta; 2011 May; 412(11-12):843-9. PubMed ID: 21396928
[TBL] [Abstract][Full Text] [Related]
54. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus.
Jorge ML; de Oliveira VN; Resende NM; Paraiso LF; Calixto A; Diniz AL; Resende ES; Ropelle ER; Carvalheira JB; Espindola FS; Jorge PT; Geloneze B
Metabolism; 2011 Sep; 60(9):1244-52. PubMed ID: 21377179
[TBL] [Abstract][Full Text] [Related]
55. Type 2 diabetes as an inflammatory disease.
Donath MY; Shoelson SE
Nat Rev Immunol; 2011 Feb; 11(2):98-107. PubMed ID: 21233852
[TBL] [Abstract][Full Text] [Related]
56. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial.
Church TS; Blair SN; Cocreham S; Johannsen N; Johnson W; Kramer K; Mikus CR; Myers V; Nauta M; Rodarte RQ; Sparks L; Thompson A; Earnest CP
JAMA; 2010 Nov; 304(20):2253-62. PubMed ID: 21098771
[TBL] [Abstract][Full Text] [Related]
57. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss.
Balducci S; Zanuso S; Nicolucci A; Fernando F; Cavallo S; Cardelli P; Fallucca S; Alessi E; Letizia C; Jimenez A; Fallucca F; Pugliese G
Nutr Metab Cardiovasc Dis; 2010 Oct; 20(8):608-17. PubMed ID: 19695853
[TBL] [Abstract][Full Text] [Related]
58. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis.
Lee CC; Adler AI; Sandhu MS; Sharp SJ; Forouhi NG; Erqou S; Luben R; Bingham S; Khaw KT; Wareham NJ
Diabetologia; 2009 Jun; 52(6):1040-7. PubMed ID: 19326095
[TBL] [Abstract][Full Text] [Related]
59. Chronic inflammation: role of adipose tissue and modulation by weight loss.
You T; Nicklas BJ
Curr Diabetes Rev; 2006 Feb; 2(1):29-37. PubMed ID: 18220615
[TBL] [Abstract][Full Text] [Related]
60. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association.
Sigal RJ; Kenny GP; Wasserman DH; Castaneda-Sceppa C; White RD
Diabetes Care; 2006 Jun; 29(6):1433-8. PubMed ID: 16732040
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
